(Q35169582)

6 August 2017

1 reference

title

Targeting the TGF beta signaling network in human neoplasia (English)

1 reference

6 August 2017

Nancy Dumont

1

1 reference

6 August 2017

Carlos L Arteaga

series ordinal

2

1 reference

6 August 2017

publication date

1 June 2003

1 reference

6 August 2017

1 reference

6 August 2017

volume

3

1 reference

6 August 2017

issue

6

1 reference

6 August 2017

page(s)

531-536

1 reference

Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900135-1

7 January 2021

Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900135-1

7 January 2021

TGFbeta1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900135-1

7 January 2021

TGF-beta signaling in tumor suppression and cancer progression

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900135-1

7 January 2021

Transforming growth factor-beta and breast cancer: Tumor promoting effects of transforming growth factor-beta

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900135-1

7 January 2021

Autocrine transforming growth factor-beta signaling mediates Smad-independent motility in human cancer cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900135-1

7 January 2021

Transforming growth factor-beta and breast cancer risk in women with mammary epithelial hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900135-1

7 January 2021

Tumor-host interactions in the gallbladder suppress distal angiogenesis and tumor growth: involvement of transforming growth factor beta1.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900135-1

7 January 2021

Immune-mediated eradication of tumors through the blockade of transforming growth factor-beta signaling in T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900135-1

7 January 2021

DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900135-1

7 January 2021

Blockade of Smad4 in transformed keratinocytes containing a Ras oncogene leads to hyperactivation of the Ras-dependent Erk signalling pathway associated with progression to undifferentiated carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900135-1

7 January 2021

Ras and TGF[beta] cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900135-1

7 January 2021

The TGF-beta signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900135-1

7 January 2021

The glioblastoma-derived T-cell suppressor factor/transforming growth factor beta 2 inhibits the generation of lymphokine-activated killer (LAK) cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900135-1

7 January 2021

Inhibition of transforming growth factor (TGF)-beta1-induced extracellular matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900135-1

7 January 2021

Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900135-1

7 January 2021

TGF-beta signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900135-1

7 January 2021

TGFbeta signaling in growth control, cancer, and heritable disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900135-1

7 January 2021

TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900135-1

7 January 2021

Blockade of TGF-beta inhibits mammary tumor cell viability, migration, and metastases.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900135-1

7 January 2021

Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900135-1

7 January 2021

TGF-beta1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900135-1

7 January 2021

TGFbeta signaling is necessary for carcinoma cell invasiveness and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900135-1

7 January 2021

Metastasis is driven by sequential elevation of H-ras and Smad2 levels.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900135-1

7 January 2021

Inhibition of mammary duct development but not alveolar outgrowth during pregnancy in transgenic mice expressing active TGF-beta 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900135-1

7 January 2021

Mammary tumor suppression by transforming growth factor beta 1 transgene expression

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900135-1

7 January 2021

Transforming growth factor beta enhances epithelial cell survival via Akt-dependent regulation of FKHRL1

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900135-1

7 January 2021

Human antitransforming growth factor beta(2) monoclonal antibody--a new modulator of wound healing in trabeculectomy: a randomized placebo controlled clinical study

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900135-1

7 January 2021

Transforming growth factor-beta1 is a new form of tumor suppressor with true haploid insufficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900135-1

7 January 2021

Enhanced expression of the type II transforming growth factor-beta receptor is associated with decreased survival in human pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900135-1

7 January 2021

Molecular predictors of survival after adjuvant chemotherapy for colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900135-1

7 January 2021

Reversal of tumor-induced immunosuppression by TGF-beta inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900135-1

7 January 2021

Haploid loss of the tumor suppressor Smad4/Dpc4 initiates gastric polyposis and cancer in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900135-1

7 January 2021

Lifetime exposure to a soluble TGF-beta antagonist protects mice against metastasis without adverse side effects

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900135-1

7 January 2021

Smad3 mutant mice develop metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900135-1

7 January 2021

Association between the T29-->C polymorphism in the transforming growth factor beta1 gene and breast cancer among elderly white women: The Study of Osteoporotic Fractures.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900135-1

7 January 2021

10.1016/S1535-6108(03)00135-1

Identifiers

DOI

1 reference

6 August 2017

1 reference